Login

Financial Snapshot

Revenue
TTM
$981.1K
Gross Margin
TTM
-676.57%
Net Income
TTM
-$12.15M
Current Assets
2024 Q3
Current Liabilities
2024 Q3
Current Ratio
2024 Q3
13.69%
Total Assets
2024 Q3
Total Liabilities
2024 Q3
Book Value
2024 Q3
-$9.788M
Cash
2024 Q3
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$368.4K

Stock Price

Loading...
Market Cap: $1.38 Million

About

Can B Corp. (formerly Canbiola, Inc.) is a company that filed a 10-K annual report with the SEC on 2024-04-15 (accession 000149315224014686) under the ticker symbol referenced in the filing. The filing excerpts provided do not contain sufficient detail to describe the company's core business activity, revenue model, competitive position, segment financials, customer base, geographic footprint, or leadership. No business-model evidence, product descriptions, financial figures, or operational data are present in the available excerpts. A complete company description cannot be constructed from the source material without risking unsupported inference. The filing identifies the registrant as Can B Corp., incorporated with common stock of nil par value per share, and confirms the company is subject to SEC reporting requirements under Section 13 or 15(d) of the Securities Exchange Act of 1934.

Source: SEC 10-K, filed 2024-04-15

Industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries Peers: Enveric Biosciences Inc AmeriCann, Inc. CNS Pharmaceuticals Inc Kiora Pharmaceuticals Inc GREEN HYGIENICS HOLDINGS INC. Johnson & Johnson Range Impact Inc Palisade Bio Inc One World Products Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support